Thank you for your interest in clinical trials for Anemia in Green Bay. Use our Clinical Trials Search to find clinical trials for other conditions or locations.
Your search returned no results. Get alerts when studies become available.
Your search returned 9 studies:Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyConditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung CancerLocation: Green Bay, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Green Bay, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Green Bay, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Green Bay, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Green Bay, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Green Bay, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Marinette, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Oconto Falls, Wisconsin Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaConditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic SyndromesLocation: Sturgeon Bay, Wisconsin
Didn't find what you were looking for? Try these alternatives: